Skip Navigation
Skip to contents

Blood Res.  2019 Dec;54(4):290-295. 10.5045/br.2019.54.4.290.

Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning

Affiliations
  • 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. stephano.dyshin@gmail.com
  • 2Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • 3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • 4Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Abstract

No abstract available.


MeSH Terms

Antilymphocyte Serum*
Humans
Leukemia*
Myelodysplastic Syndromes*
Peripheral Blood Stem Cell Transplantation*
Tissue Donors*
Antilymphocyte Serum
Full Text Links
  • BR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr